Amgen Inc. (AMGN) Stock Forecast
AMGN analyst forecast
as of October 18, 2026- Analyst consensus
- Hold 3.35 / 5 from 34 analysts
- Price target
- $394.98 average of analyst targets
- Upside to target
- −8.7% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $5.72
- 52-week range
- $291.16 – $444.12
AMGN analyst ratings
34 analystsNumber of analysts at each rating.
AMGN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
AMGN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.76 | $5.47 | $6.07 | $5.64 | +2.2% | 28 |
| Current fiscal year (2026) | $23.02 | $22.49 | $23.44 | $21.84 | +5.4% | 33 |
| Next fiscal year (2027) | $24.50 | $22.88 | $26.37 | $23.02 | +6.4% | 31 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
AMGN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $10.06B | $9.85B | $10.28B | +5.3% | 25 |
| Current fiscal year (2026) | $38.97B | $38.40B | $39.46B | +6.0% | 31 |
| Next fiscal year (2027) | $40.36B | $38.80B | $44.05B | +3.6% | 29 |
AMGN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
AMGN revenue: reported and forecast
AMGN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.74 | $5.79 | $5.78 | $5.76 | $5.76 | +0.4% | 2 up · 3 down |
| Current fiscal year (2026) | $22.33 | $22.99 | $23.04 | $23.04 | $23.02 | +3.1% | 3 up · 3 down |
| Next fiscal year (2027) | $23.45 | $24.28 | $24.40 | $24.48 | $24.50 | +4.5% | 7 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
AMGN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; AMGN beat in 11 of 12.
What analysts expect from AMGN
34 analysts cover Amgen; their consensus rating is hold (3.35 on a 1–5 scale, where 5 is a strong buy). The average price target is $394.98, 8.7% below the latest close of $432.49. Analysts expect earnings of $23.02 per share for 2026, +5.4% from a year earlier. For 2027 the average estimate is $24.50 per share on revenue of $40.4 billion. Amgen beat the EPS estimate in 11 of the last 12 quarters.
Related: AMGN income statement, AMGN key metrics, AMGN chart. See the AMGN stock overview for the latest quote and news.
AMGN forecast FAQ
What is Amgen's price target?
The average analyst price target for Amgen is $394.98, 8.7% below the latest close of $432.49.
Is Amgen a buy, hold or sell?
Of 34 analysts covering Amgen, 8 rate it a strong buy, 4 a buy, 17 a hold, 2 a sell and 3 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is Amgen's EPS forecast?
Analysts forecast $23.02 per share for 2026 (range $22.49 to $23.44); for 2027 the estimate is $24.50.
What is Amgen's revenue forecast?
The average revenue estimate for 2026 is $39.0 billion, growth of 6.0%; for 2027 it is $40.4 billion.
When does Amgen report earnings?
Amgen is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $5.72.
Does Amgen usually beat earnings estimates?
Amgen reported EPS at or above the analyst estimate in 11 of the last 12 quarters.